Clinical trial Recruiting at 4 sites Observational Ages 18 and up

Outcomes of Pyrocarbon Implants for Hand and Wrist Surgery

Official title: Hand & Wrist Pyrocarbon Implants Outcomes Clinical Study

Run by Stryker Trauma and Extremities · NCT04137237 · Data updated 2026-11-12

This study is trying to see how safe and effective Pyrocarbon implants are for people undergoing hand and wrist surgeries by collecting information over the next 10 years.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment417 (estimated)
SponsorStryker Trauma and Extremities
Industry-sponsored
Locations4 sites (Lyon and 3 other locations)
StatusRecruiting
StartedNovember 14, 2019
Main results expectedJanuary 2029
Study endsJanuary 2033
Registry record updatedSeptember 16, 2025
Trial IDNCT04137237 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include adults aged 18 and older who are undergoing primary or revision surgery with Pyrocarbon hand or wrist implants.

Probably not a fit

Patients who are part of vulnerable populations as defined by French law may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This international observational study aims to collect post-market safety and performance data on commercially available Pyrocarbon implants used in hand and wrist surgeries. It will gather data at various stages, including preoperative, intraoperative, and long-term postoperative periods, to assess clinical complications and outcomes associated with these implants. The study is designed to demonstrate the safety and effectiveness of Pyrocarbon implants in real-world clinical settings over a span of up to 10 years.

Why it matters

Potential benefit: If successful, this study could provide valuable insights into the long-term safety and effectiveness of Pyrocarbon implants, potentially improving patient outcomes in hand and wrist surgeries.

How similar studies have gone: Other studies on post-market surveillance of orthopedic implants have shown success in demonstrating safety and performance, indicating that this approach is validated.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* 18 years or older at the time he/she receives the information and signs the informed consent (when applicable as per local regulatory requirements),
* Informed on the study and willing to sign an informed consent form approved by Institutional Review Board or Ethics Committee,
* Willing and able to comply with the requirements of the study protocol,
* For prospective inclusion: considered for treatment with one of PyC Hand/Wrist study implants (primary or revision surgery),
* For "ambispective" inclusion: must have undergone a Hand or Wrist arthroplasty with a PyC Hand/Wrist study implant before the date of first site initiation visit,

  * Follow-up visits (at least the last two) must be prospective,
  * Patient must have complete information available for each completed visit

Exclusion Criteria:

* Patient pertaining to one of the categories referred to as "vulnerable population" in the French Law (articles L. 1121-5 to L. 1121-8 of the French Public Health Code), or as "particularly vulnerable persons" in the Swiss Federal Law (Chapter 3, Sections 1 to 4 of CC 810.30 Federal Act on Research involving Human Beings - Human Research Act, HRA),
* Patient unable to comply with the study procedures based on the judgment of the investigator (e.g. cannot comprehend study questions, inability to keep scheduled assessment times),
* Any medical condition that could impact on the study outcomes functional signification at the investigator's discretion (e.g., neuropathy, allergy…)

Where it's running

  • Clinique du Parc
    Lyon, France
    Recruiting
  • Espace Médical Vauban
    Paris, France
    Recruiting
  • Institut de la Main Nantes-Atlantique - Pôle Santé-Atlantique
    Saint-Herblain, France
    Recruiting
  • Orthopedic Surgeon (Dr. med. Dietmar Bignion)
    Bern, Switzerland
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.